Resident CD141 (BDCA3) + dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

Journal of Experimental Medicine

Volumn 209, Issue 5, 2012, Pages 935-945

  Chu, Chung Ching ^a,d   Ali, Niwa ^a,b   Karagiannis, Panagiotis ^a   Di Meglio, Paola ^a   Skowera, Ania ^c   Napolitano, Luca ^a   Barinaga, Guillermo ^a   Grys, Katarzyna ^a   Sharif Paghaleh, Ehsan ^b   Karagiannis, Sophia N ^a   Peakman, Mark ^c   Lombardi, Giovanna ^b   Nestle, Frank O ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD14 ANTIGEN; CD141 ANTIGEN; CD163 ANTIGEN; CD1C ANTIGEN; CD205 ANTIGEN; CD209 ANTIGEN; COLECALCIFEROL; INTERLEUKIN 10; LANGERIN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; 4',6 DIAMIDINO 2 PHENYLINDOLE; BLOOD DENDRITIC CELL ANTIGEN 3, HUMAN; IL2RG PROTEIN, MOUSE; INDOLE DERIVATIVE; INTERLEUKIN 2 RECEPTOR GAMMA; MEMBRANE ANTIGEN;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD25+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DERMIS; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN INFLAMMATION; XENOGRAFT; ANALYSIS OF VARIANCE; ANIMAL; BIOLOGICAL THERAPY; DERMATITIS; DRUG EFFECT; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; LANGERHANS CELL; METABOLISM; METHODOLOGY; MOUSE MUTANT; NONOBESE DIABETIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD14; ANTIGENS, SURFACE; CHOLECALCIFEROL; DERMATITIS; FEMALE; GRAFT VS HOST DISEASE; HOMEOSTASIS; HUMANS; INDOLES; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKIN-10; LANGERHANS CELLS; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; T-LYMPHOCYTES, REGULATORY; TISSUE THERAPY;

EID: 84863800955     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20112583     Document Type: Article

References (45)

1. Adorini, L., N. Giarratana, and G. Penna. 2004. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16:127- 134. http://dx.doi.org/10.1016/j.smim.2003.12.008
2. Anas, A., T. van der Poll, and A.F. de Vos. 2010. Role of CD14 in lung inflammation and infection. Crit. Care. 14:209. http://dx.doi.org/10.1186/cc8850
3. Azukizawa, H., A. Döhler, N. Kanazawa, A. Nayak, M. Lipp, B. Malissen, I. Autenrieth, I. Katayama, M. Riemann, F. Weih, et al. 2011. Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells. Eur. J. Immunol. 41:1420-1434. http://dx.doi.org/10.1002/eji.201040930
4. Bachem, A., S. Güttler, E. Hartung, F. Ebstein, M. Schaefer, A. Tannert, A. Salama, K. Movassaghi, C. Opitz, H.W. Mages, et al. 2010. Superior antigen crosspresentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207:1273- 1281. http://dx.doi.org/10.1084/jem.20100348
5. Bedoui, S., P.G. Whitney, J. Waithman, L. Eidsmo, L. Wakim, I. Caminschi, R.S. Allan, M. Wojtasiak, K. Shortman, F.R. Carbone, et al. 2009. Crosspresentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10:488-495. http://dx.doi.org/10.1038/ni.1724
6. Burgdorf, S., V. Lukacs-Kornek, and C. Kurts. 2006. The mannose receptor mediates uptake of soluble but not of cell-associated antigen for crosspresentation. J. Immunol. 176:6770-6776.
7. Caux, C., B. Vanbervliet, C. Massacrier, C. Dezutter-Dambuyant, B. de Saint-Vis, C. Jacquet, K. Yoneda, S. Imamura, D. Schmitt, and J. Banchereau. 1996. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184:695-706. http://dx.doi.org/10.1084/jem.184.2.695
8. Chang, C.C., R. Ciubotariu, J.S. Manavalan, J. Yuan, A.I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237-243. http://dx.doi.org/10.1038/ni760
9. Contreras, V., C. Urien, R. Guiton, Y. Alexandre, T.P. Vu Manh, T. Andrieu, K. Crozat, L. Jouneau, N. Bertho, M. Epardaud, et al. 2010. Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J. Immunol. 185:3313-3325. http://dx.doi.org/10.4049/jimmunol.1000824
10. Crozat, K., R. Guiton, V. Contreras, V. Feuillet, C.A. Dutertre, E. Ventre, T.P. Vu Manh, T. Baranek, A.K. Storset, J. Marvel, et al. 2010. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207:1283-1292. http://dx.doi.org/10.1084/jem.20100223
11. Demedts, I.K., G.G. Brusselle, K.Y. Vermaelen, and R.A. Pauwels. 2005. Identification and characterization of human pulmonary dendritic cells. Am. J. Respir. Cell Mol. Biol. 32:177-184. http://dx.doi.org/10.1165/ rcmb.2004-0279OC
12. Dhodapkar, M.V., R.M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233-238. http://dx.doi.org/10.1084/jem.193.2.233
13. Fiore, N., G. Castellano, A. Blasi, C. Capobianco, A. Loverre, V. Montinaro, S. Netti, D. Torres, C. Manno, G. Grandaliano, et al. 2008. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol. Immunol. 45:259-265. http://dx.doi.org/10.1016/j.molimm.2007.04.029
14. Heath, W.R., and F.R. Carbone. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10:1237- 1244. http://dx.doi.org/10.1038/ni.1822
15. Henri, S., L.F. Poulin, S. Tamoutounour, L. Ardouin, M. Guilliams, B. de Bovis, E. Devilard, C. Viret, H. Azukizawa, A. Kissenpfennig, and B. Malissen. 2010. CD207+ CD103+ dermal dendritic cells crosspresent keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207:189-206. http://dx.doi.org/10.1084/ jem.20091964
16. Jongbloed, S.L., A.J. Kassianos, K.J. McDonald, G.J. Clark, X. Ju, C.E. Angel, C.J. Chen, P.R. Dunbar, R.B. Wadley, V. Jeet, et al. 2010. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207:1247-1260. http://dx.doi.org/10.1084/jem.20092140
17. Jonuleit, H., U. Kühn, G. Müller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A.H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:3135-3142. http:// dx.doi.org/10.1002/eji.1830271209
18. Jonuleit, H., E. Schmitt, G. Schuler, J. Knop, and A.H. Enk. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213-1222. http://dx.doi.org/10.1084/ jem.192.9.1213
19. King, M.A., L. Covassin, M.A. Brehm, W. Racki, T. Pearson, J. Leif, J. Laning, W. Fodor, O. Foreman, L. Burzenski, et al. 2009. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin. Exp. Immunol. 157:104-118. http://dx.doi.org/10.1111/ j.1365-2249.2009.03933.x
20. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C.H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 22:643-654. http://dx.doi.org/10.1016/ j.immuni.2005.04.004
21. Klechevsky, E., R. Morita, M. Liu, Y. Cao, S. Coquery, L. Thompson-Snipes, F. Briere, D. Chaussabel, G. Zurawski, A.K. Palucka, et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 29:497-510. http://dx.doi.org/10.1016/ j.immuni.2008.07.013
22. Larregina, A.T., A.E. Morelli, L.A. Spencer, A.J. Logar, S.C. Watkins, A.W. Thomson, and L.D. Falo Jr. 2001. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2:1151-1158. http://dx.doi.org/10.1038/ni731
23. Lenz, A., M. Heine, G. Schuler, and N. Romani. 1993. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92:2587- 2596. http://dx.doi.org/10.1172/JCI116873
24. Liu, K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba, and R.M. Steinman. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:1091-1097. http://dx.doi.org/10.1084/ jem.20021215
25. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science. 264:1587-1589. http://dx.doi.org/10.1126/science.8202711
26. Lutz, M.B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:445-449. http://dx.doi.org/10.1016/S1471-4906(02)02281-0
27. Merad, M., and M.G. Manz. 2009. Dendritic cell homeostasis. Blood. 113:3418- 3427. http://dx.doi.org/10.1182/blood-2008-12-180646
28. Narbutt, J., A. Lesiak, A. Sysa-Jedrzejowska, P. Smolewski, T. Robak, and A. Zalewska. 2006. The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects. Folia Histochem. Cytobiol. 44:61-63.
29. Nestle, F.O., X.G. Zheng, C.B. Thompson, L.A. Turka, and B.J. Nickoloff. 1993. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151:6535-6545.
30. Nestle, F.O., P. Di Meglio, J.Z. Qin, and B.J. Nickoloff. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9:679-691.
31. Penna, G., N. Giarratana, S. Amuchastegui, R. Mariani, K.C. Daniel, and L. Adorini. 2005. Manipulating dendritic cells to induce regulatory T cells. Microbes Infect. 7:1033-1039. http://dx.doi.org/10.1016/j.micinf.2005.03.025
32. Poulin, L.F., M. Salio, E. Griessinger, F. Anjos-Afonso, L. Craciun, J.L. Chen, A.M. Keller, O. Joffre, S. Zelenay, E. Nye, et al. 2010. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J. Exp. Med. 207:1261-1271. http://dx.doi.org/10.1084/jem.20092618
33. Raife, T.J., D.J. Lager, K.C. Madison, W.W. Piette, E.J. Howard, M.T. Sturm, Y. Chen, and S.R. Lentz. 1994. Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J. Clin. Invest. 93:1846-1851. http://dx.doi.org/10.1172/ JCI117171
34. Reis e Sousa, C. 2006. Dendritic cells in a mature age. Nat. Rev. Immunol. 6:476-483. http://dx.doi.org/10.1038/nri1845
35. Rizzitelli, A., D. Vremec, J.A. Villadangos, N. Mavaddat, M.D. Wright, and K. Shortman. 2005. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Tolllike receptor 9 ligand. Eur. J. Immunol. 35:3209-3220. http://dx.doi.org/ 10.1002/eji.200526231
36. Robbins, S.H., T. Walzer, D. Dembélé, C. Thibault, A. Defays, G. Bessou, H. Xu, E. Vivier, M. Sellars, P. Pierre, et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9:R17. http://dx.doi.org/10.1186/gb-2008-9-1-r17
37. Sagoo, P., N. Ali, G. Garg, F.O. Nestle, R.I. Lechler, and G. Lombardi. 2011. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 3:ra42. http://dx.doi.org/10.1126/scitranslmed.3002076
38. Sancho, D., O.P. Joffre, A.M. Keller, N.C. Rogers, D. Martínez, P. Hernanz-Falcón, I. Rosewell, and C. Reis e Sousa. 2009. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature. 458:899-903. http://dx.doi.org/10.1038/nature07750
39. Schwarz, T., and A. Schwarz. 2011. Molecular mechanisms of ultraviolet radiation-induced immunosuppression. Eur. J. Cell Biol. 90:560-564. http://dx.doi.org/10.1016/j.ejcb.2010.09.011
40. Skowera, A., R.J. Ellis, R. Varela-Calviño, S. Arif, G.C. Huang, C. Van-Krinks, A. Zaremba, C. Rackham, J.S. Allen, T.I. Tree, et al. 2008. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J. Clin. Invest. 118:3390-3402.
41. Steinman, R.M., D. Hawiger, and M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711. http://dx.doi.org/10.1146/ annurev.immunol.21.120601.141040
42. Swamy, M., C. Jamora, W. Havran, and A. Hayday. 2010. Epithelial decision makers: in search of the 'epimmunome'. Nat. Immunol. 11:656- 665. http://dx.doi.org/10.1038/ni.1905
43. Tsoumakidou, M., N. Tzanakis, H.A. Papadaki, H. Koutala, and N.M. Siafakas. 2006. Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol. Cell Biol. 84:267- 273. http://dx.doi.org/10.1111/j.1440-1711.2006.01428.x
44. Waithman, J., R.S. Allan, H. Kosaka, H. Azukizawa, K. Shortman, M.B. Lutz, W.R. Heath, F.R. Carbone, and G.T. Belz. 2007. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted selfreactive T cells. J. Immunol. 179:4535-4541.
45. Zaba, L.C., J. Fuentes-Duculan, R.M. Steinman, J.G. Krueger, and M.A. Lowes. 2007. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 117:2517-2525. http://dx.doi.org/10.1172/JCI32282